Kymera Therapeutics Inc
KYMR
Equity
ISIN null / Valor 56388008
NASDAQ (2026-10-06)
USD 105.98-3.52%
Kymera Therapeutics Inc
UMushroom community rating:
About company
Kymera Therapeutics Inc. is a biopharmaceutical company focused on developing targeted protein degradation therapies.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
84.2%1Y
612%3Y
71.5%5Y
Performance
58.9%1Y
67.5%3Y
70.9%5Y
Volatility
8812 M
Market cap (USD)
960,714
Daily traded volume (Shares)
39.69 / 38.29
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
